文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

评估脓毒症预防、治疗或诊断中可能被错过的机会:基于保险理赔数据的全人群回顾性研究

Evaluating Potential Missed Opportunities to Prevent, Treat, or Diagnose Sepsis: A Population-Based Retrospective Study of Insurance Claims.
PubMed 文献 · Crit Care Explor · 2025-04-02
一句话结论约16.57%的脓毒症患者可能存在诊断延迟,平均延迟3.21天,多发生在门诊,使用抗生素、阿片类药物或吸入剂者延迟风险更高。

该研究利用Merative MarketScan保险理赔数据,对2016至2019年649,756例脓毒症患者进行回顾性病例交叉分析,比较诊断前14天感染、免疫或器官功能障碍症状的就诊趋势。约16.57%(95%CI 16.38-16.78)的患者存在潜在诊断延迟,平均延迟3.21天(95%CI 3.13-3.27),中位2天,多数延迟发生在门诊。使用抗生素(OR 2.58,95%CI 2.54-2.62)、阿片类药物(OR 1.43,95%CI 1.40-1.46)或吸入剂(OR 1.37,95%CI 1.33-1.40)的患者延迟更频繁。提示门诊存在大量可能被错过的脓毒症诊断机会。

要点

  • 约16.57%(95%CI 16.38-16.78)的脓毒症患者存在潜在诊断延迟,平均延迟3.21天(95%CI 3.13-3.27),中位2天。
  • 大多数潜在诊断延迟发生在门诊场所。
  • 使用抗生素的患者发生诊断延迟的OR为2.58(95%CI 2.54-2.62)。
  • 使用阿片类药物(OR 1.43,95%CI 1.40-1.46)或吸入剂(OR 1.37,95%CI 1.33-1.40)的患者诊断延迟更频繁。
  • 年轻年龄组患者中潜在诊断延迟更常见。

适用人群与场景

  • 2016至2019年Merative MarketScan保险理赔数据中符合纳入标准的脓毒症患者,共649,756例。

研究设计与关键结果

  • 研究类型为回顾性病例交叉分析,数据来源为Merative MarketScan保险理赔,纳入2016至2019年649,756例脓毒症患者。
  • 在脓毒症索引诊断前14天内,感染、免疫或器官功能障碍症状(如发热、呼吸困难)的就诊次数增加。
  • 约16.57%(95%CI 16.38-16.78)的患者经历潜在诊断延迟,平均延迟3.21天(95%CI 3.13-3.27),中位2天。
  • 大多数延迟发生在门诊场所。
  • 潜在诊断延迟在年轻年龄组中更频繁。
  • 接受抗生素治疗的患者发生延迟的OR为2.58(95%CI 2.54-2.62)。
  • 接受阿片类药物治疗的患者发生延迟的OR为1.43(95%CI 1.40-1.46)。
  • 接受吸入剂治疗的患者发生延迟的OR为1.37(95%CI 1.33-1.40)。

证据类型、等级与局限

  • 证据类型:回顾性病例交叉分析(基于保险理赔数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为可能存在大量潜在被错过的脓毒症诊断机会,尤其在门诊场所。
  • 作者认为多种因素可能促成脓毒症诊断延迟,包括常用的症状治疗药物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Delays in diagnosing sepsis may increase morbidity and mortality, but the frequency of delays is poorly understood.

OBJECTIVES: The aim of this study was to estimate the frequency and duration of diagnostic delays for sepsis and potential risk factors for delay.

DESIGN, SETTING, AND PARTICIPANTS: We conducted a retrospective case-crossover analysis of sepsis cases from 2016 to 2019 using claims from Merative MarketScan. We ascertained the index diagnosis of sepsis and corresponding hospitalization. We analyzed healthcare visits in the 180 days before diagnosis and then compared the observed and expected trends in signs or symptoms of infection, immune or organ dysfunction (e.g., fever, dyspnea) during the 14 days before diagnosis. A bootstrapping approach was used to estimate the frequency and duration of potential diagnostic delays along with possible risk-factors for experiencing a delay.

MAIN OUTCOMES AND MEASURES: The number of patients who experienced a potential diagnostic delay, duration of delay, and number of potential missed opportunities.

RESULTS: We identified a total of 649,756 cases of sepsis from 2016 to 2019 meeting inclusion criteria. There was an increase in visits with signs or symptoms of infection, immune or organ dysfunction just before the index diagnosis of sepsis. We estimated that around 16.57% (95% CI, 16.38-16.78) of patients experienced a potential diagnostic delay, with a mean delay duration of 3.21 days (95% CI, 3.13-3.27) and a median of 2 days. Most delays occurred in outpatient settings. Potential diagnostic delays were more frequent among younger age groups and patients who received antibiotics (odds ratio [OR] 2.58 [95% CI, 2.54-2.62]), or treatments for particular symptoms, including opioids (OR 1.43 [95% CI, 1.40-1.46]) and inhalers (OR 1.37 [95% CI, 1.33-1.40]).

CONCLUSIONS AND RELEVANCE: There may be a substantial number of potential missed opportunities to diagnose sepsis, especially in outpatient settings. Multiple factors might contribute to delays in diagnosing sepsis including commonly prescribed medications for symptoms.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Struble RD, Arakkal AT, Cavanaugh JE, et al. Evaluating Potential Missed Opportunities to Prevent, Treat, or Diagnose Sepsis: A Population-Based Retrospective Study of Insurance Claims. Crit Care Explor. 2025. PMID: 40172282. doi:10.1097/CCE.0000000000001240

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。